Delivery Order SPE2DP15D0003-1318
Award Date 11/19/15
Potential Completion Date 12/21/15
Potential Value $98K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20878, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to MedImmune Biologics, Inc. for the provision of influenza virus vaccines. The contract has a total ceiling value of $95,527.50 and an ultimate completion date of December 21, 2015. The contract was not set aside for any specific business type. MedImmune Biologics, Inc. is the prime contractor for this award, which is part of the Medical Supply Chain program within the Department of Defense.</p>
- <p>This is a federal contract award from the Defense agency Medical Supply Chain to Medimmune Biologics, Inc. for influenza virus vaccines. The contract has a ceiling value of $170,730.00 and was awarded on November 19, 2015 with a completion date of December 21, 2015. The contract is a Firm Fixed Price Delivery Order with no set-aside designation. As the prime contractor, Medimmune Biologics, Inc. will be responsible for delivering the requested influenza virus vaccines to the government.</p>
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. for the supply of influenza virus vaccine. The contract has a ceiling value of $1,984.50 and a period of performance ending on July 25, 2022. The contract was awarded on October 9, 2014 and does not have a set-aside designation. As Medimmune Biologics, Inc. is a for-profit organization, they are the prime contractor on this contract, with no subcontractors mentioned....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Medimmune Biologics, Inc. for the provision of influenza virus vaccine. The contract has a value of $2,646.00 and was awarded on October 9, 2014, with a final completion date of July 25, 2022. The contract is a firm fixed-price type and does not have a set-aside designation. As the prime contractor, Medimmune Biologics, Inc. will be responsible for delivering the required influenza virus vaccine. This contract...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company that specializes in the development, manufacturing, and delivery of influenza vaccines. The contract has a ceiling value of $2,908,197.50 and an ultimate completion date of October 13, 2023. It is a firm fixed-price contract for the delivery of influenza virus vaccines. The contract is not set aside for any specific type of...
- This is a firm fixed-price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to MedImmune LLC on September 12, 2013. The contract has a ceiling value of $5,625,000.00 and a period of performance through August 31, 2015. It was awarded under the Pandemic Influenza Preparedness and Response 2012-2016 master indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract does not have a set-aside designation. As a...
- This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 6, a civilian agency within the Department of Veterans Affairs, to Seqirus USA Inc. for the delivery of Seqirus influenza vaccines. The contract has a ceiling value of $165,361.50 and a completion date of June 14, 2025. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Seqirus holds with the VA National Acquisition Center, valued at $69.1 million, and potentially other IDCs...
- This $642,000.00 firm-fixed-price delivery order was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Seqirus USA Inc. through its Seqirus Usa, Inc. division. The order was placed under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Contract, a multi-year vehicle managed by ASPR. The contract supports the delivery of influenza vaccines, which Seqirus specializes in manufacturing and supplying to various...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,102,020.00 firm fixed-price delivery order contract to Seqirus USA Inc., a foreign-owned, for-profit biotechnology company, for the supply of influenza virus vaccines. The contract has an ultimate completion date of October 13, 2023. This delivery order is part of Seqirus's existing Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency and Centers for Disease Control and Prevention, which allow federal agencies...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to Seqirus USA Inc. on February 18, 2026, with a ceiling value of $10.7 million for influenza virus vaccines, with ultimate completion on September 25, 2026. Place of performance is Summit, NJ. The delivery order is firm fixed price with no set-aside. This order is issued under a parent indefinite delivery contract with the Medical Supply Chain for injectable influenza virus vaccines in multiple presentations...